Melissa B. Epperly, Director: Roivant Sciences ROIV Planned sale · Filed 03/16

Trade details

Type: Planned sale notice
Stock: Roivant Sciences ROIV
Person: Melissa B. EpperlyDirector
Planned sale date: 26/03/16
Filed: 26/03/16

$1.2M to be sold

Roivant Sciences trades, last 26 weeks

What else happened in Roivant Sciences around then

Filed or reported within 30 days of the trade day · 02/14~04/15

Melissa B. Epperly's recent trades

Melissa B. EpperlyDirector
Planned sale10b5-1 planRoivant Sciences
Planned sale10b5-1 plan
Roivant Sciences
ROIV
$930.7K
22,688 sh
$930.7K
Filed 09/15
Traded 09/15
Melissa B. EpperlyDirector
Planned sale10b5-1 planRoivant Sciences
Planned sale10b5-1 plan
Roivant Sciences
ROIV
$604.7K
17,750 sh
$604.7K
Filed 06/29
Traded 06/29
Melissa B. EpperlyDirector
SellRoivant Sciences
Sell
Roivant Sciences
ROIV
$1.2M
41,861 sh
$1.2M
Filed 03/18
Traded 03/16
Melissa B. EpperlyCFO
SellZentalis Pharmaceuticals
Sell
Zentalis Pharmaceuticals
ZNTL
$29.4K
2,573 sh
$29.4K
Filed 24/02/12
Traded 24/02/12
Melissa B. EpperlyCFO
SellZentalis Pharmaceuticals
Sell
Zentalis Pharmaceuticals
ZNTL
$100K
8,669 sh
$100K
Filed 24/02/05
Traded 24/02/02

Melissa B. Epperly, Director — plans to sell 41,861 sh of Roivant Sciences ROIV · $1.2M · around 03/16 | Whalegun